Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activities

International Journal of Cardiology

Volumn 134, Issue 3, 2009, Pages 356-365

  Cheng, Bei ^a   Song, Jian ^a,b   Zou, Yun ^a   Wang, Qiao ^a   Lei, Yueshan ^a   Zhu, Congli ^a   Hu, Chengjun ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Estrogen; MAP kinase; Proliferation; Vascular smooth muscle cell

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67349286838     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.02.017     Document Type: Article

References (45)

1. Baker L., Meldrum K.K., Wang M., et al. The role of estrogen in cardiovascular disease. J Surg Res 115 (2003) 325-344
2. Shen J., White M., Husband A.J., Hambly B.D., and Bao S. Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model. Eur J Pharmacol 548 (2006) 123-128
3. Rhee C.Y., Spaet T.H., Stemerman M.B., et al. Estrogen suppression of surgically induced vascular intimal hyperplasia in rabbits. J Lab Clin Med 90 (1977) 77-84
4. Foegh M.L., Asotra S., Howell M.H., and Ramwell P.W. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 19 (1994) 722-726
5. Cheng L.P., Kuwahara M., Jacobsson J., and Foegh M.L. Inhibition of myointimal hyperplasia and macrophage infiltration by estrogen in aorta allografts. Transplantation 52 (1991) 967-972
6. Sullivan Jr. T.R., Karas R.H., Aronovitz M., et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 96 (1995) 2482-2488
7. Takahashi K., Ohmichi M., Yoshida M., et al. Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells. Endocrinol 178 (2003) 319-329
8. Montague C.R., Hunter M.G., Gavrilin M.A., Phillips G.S., Goldschmidt-Clermont P.J., and Marsh C.B. Activation of estrogen receptor-alpha reduces aortic smooth muscle differentiation. Circ Res 99 (2006) 477-484
9. Akishita M., Ouchi Y., Miyoshi H., et al. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis 130 (1997) 1-10
10. Kappert K., Caglayan E., Huntgeburth M., et al. 17 beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. Am J Physiol, Heart Circ Physiol 290 (2006) H538-H546
11. Vargas R., Wroblewska B., Rego A., Hatch J., and Ramwell P.W. Oestrogen inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 109 (1993) 612-617
12. Dai-Do D., Espinosa E., Liu G., et al. 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. Cardiovasc Res 32 (1996) 980-985
13. Suzuki A., Mizuno K., Ino Y., et al. Effects of 17 beta-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovasc Res 32 (1996) 516-523
14. Bhalla R.C., Toth K.F., Bhatty R.A., Thompson L.P., and Sharma R.V. Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells. Am J Physiol 272 (1997) H1996-H2003
15. Ling S., Dai A., Dilley R.J., et al. Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse. Circulation 109 (2004) 537-543
16. Keyes L.E., Moore L.G., Walchak S.J., and Dempsey E.C. Pregnancy stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factors. J Cell Physiol 166 (1996) 22-32
17. Farhat M.Y., Vargas R., Dingaan B., and Ramwell P.W. In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium. Br J Pharmacol 107 (1992) 679-683
18. Song J., Wan Y., Rolfe B.E., Campbell J.H., and Campbell G.R. Effects of estrogen on vascular smooth muscle cells is dependent upon cellular phenotype. Atherosclerosis 140 (1998) 97-104
19. Mori-Abe A., Tsutsumi S., Takahashi K., et al. Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells. J Endocrinol 178 (2003) 417-426
20. Yang Z., Cheng B., Song J., et al. Estrogen accelerates G1 to S phase transition and induces a G2/M phase-predominant apoptosis in synthetic vascular smooth muscle cells. Int J Cardiol 118 (2007) 381-388
21. Marais R., and Marshall C.J. Control of the ERK MAP kinase cascade by ras and raf. Cancer Surv 27 (1996) 101-125
22. Minden A., Lin A., McMahon M., et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 226 (1994) 1719-1723
23. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
24. Raingeaud J., Gupta S., Rogers J.S., et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270 (1995) 7420-7426
25. Campbell J.H., Kocher O., Skalli O., Gabbiani G., and Campbell G.R. Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells: Correlation with cell density and proliferative state. Arteriosclerosis 9 (1989) 633-643
26. Helguero L.A., Faulds M.H., Gustafsson J.A., and Haldosén L.A. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24 (2005) 6605-6616
27. Lee H.Y., and Sherwood O.D. The effects of blocking the actions of estrogen and progesterone on the rates of proliferation and apoptosis of cervical epithelial and stromal cells during the second half of pregnancy in rats. Biol Reprod 73 (2005) 790-797
28. Hulguero L.A., Faulds M.H., Gustafsson J.A., and Haldosen L.A. Estrogen receptor alpha (ERα) and beta (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24 (2005) 6605-6616
29. Acconcia F., Totta P., Ogawa S., et al. Survival versus apoptotic 17β-estradiol effect: role of ERα and ERβ activated non-genomic signaling. J Cell Physiol 203 (2005) 193-201
30. Fernando R.I., and Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell 15 7 (2004) 3266-3284
31. Karas R.H., Hodgin J.B., Kwoun M., et al. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci U S A 96 26 (1999) 15133-15136
32. Tsuchiya Y., Nakajima M., and Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 227 (2005) 115-124
33. Favata M.F., Horiuchi K.Y., Manos E.J., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273 (1998) 18623-18632
34. Kang Y.J., Seit-Nebi A., Davis R.J., and Han J. Multiple activation mechanisms of p38α mitogen-activated protein kinase. J Biol Chem 281 (2006) 26225-26234
35. Makeeva N., Roomans G.M., and Welsh N. Role of TAB1 in nitric oxide-induced p38 activation in insulin-producing cells. Int J Biol Sci 3 (2007) 71-76
36. DeSilva D.R., Jones E.A., Favata M.F., et al. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J Immunol 160 (1998) 4175-4181
37. Wang Z., Canagarajah B.J., Boehm J.C., et al. Structural basis of inhibitor selectivity in MAP kinases. Structure 6 (1998) 1117-1128
38. Singh R.P., Dhawan P., Golden C., Kapoor G.S., and Mehta K.D. One-way cross-talk between p38(MAPK) and p42/44(MAPK). Inhibition of p38 (MAPK) induces low-density lipoprotein receptor expression through activation of the p42/44(MAPK) cascade. J Biol Chem 274 (1999) 19593-19600
39. Aguirre-Ghiso J.A., Liu D., Mignatti A., Kovalski K., and Ossowski L. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38 (MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12 (2001) 863-879
40. Hotokezaka H., Sakai E., Kanaoka K., et al. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277 (2002) 47366-47372
41. Liu Q., and Hofmann P.A. Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am J Physiol, Heart Circ Physiol 286 (2004) H2204-H2212
42. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr Opin Cell Biol 12 (2000) 186-192
43. Dickinson R.J., and Keyse S.M. Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci 119 (2006) 4607-4615
44. Wu J.J., and Bennett A.M. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling. J Biol Chem 280 (2005) 16461-16466
45. Zhou J.Y., Liu Y., and Wu G.S. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Cancer Res 66 (2006) 1-7